HighTower Advisors’s Icosavax, Inc. Common Stock ICVX Stock Holding History

HighTower Advisors’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-59,096	Closed	-$931K	–	4107
2023 Q4	$931K	Buy	59,096 +20	+0%	+$193	﹤0.01%	1872
2023 Q3	$458K	Hold	59,076	–	–	﹤0.01%	2289
2023 Q2	$587K	Hold	59,076	–	–	﹤0.01%	2086
2023 Q1	$343K	Hold	59,076	–	–	﹤0.01%	2366
2022 Q4	$469K	Buy	+59,076	New	+$254K	﹤0.01%	2170

HighTower Advisors's ICVX Position: Q1 2024 in Review

HighTower Advisors sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 59,096 shares — an estimated $931K sold.

HighTower Advisors first reported a position in ICVX in Q4 2022 and held it in 5 quarters. The position peaked at $931K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

HighTower Advisors reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
HighTower Advisors sold 59,096 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $931K.
HighTower Advisors first reported a position in Icosavax, Inc. Common Stock in Q4 2022 and held it in 5 quarters.
HighTower Advisors's Icosavax, Inc. Common Stock position peaked at $931K in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on HighTower Advisors's 13F filing for Q1 2024, filed 6 May 2024.